Skip to main content

Loading market ticker...

Windlas Biotech

Healthcare NSE:WINDLAS

764.50INR
-3.15 ( -0.41%)

Last update at April 2, 2026, midnight

Day Range

747.15788.95
LowHigh

52 Week Range

660.92 1132.84
LowHigh

Fundamentals

  • Previous Close 767.65
  • Market Cap 16029.28M
  • Volume37,650
  • P/E Ratio 23.94
  • EBITDA 1021.14M
  • Revenue TTM 8302.12M
  • Revenue Per Share TTM 396.23
  • Gross Profit TTM 3145.76M
  • Diluted EPS TTM 31.76

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 797.58M 770.91M 570.39M 455.65M 217.40M
Net income 609.94M 581.87M 426.26M 380.89M 158.32M
Total Revenue 7598.78M 6288.85M 5130.83M 4633.73M 4267.12M
Gross Profit 2880.23M 2284.69M 1876.36M 1605.57M 1523.07M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 7604.50M 6262.06M 5289.75M 4910.11M 2961.23M
Intangible assets 67.79M 44.68M 14.84M 8.81M 4.82M
Other current assets 365.86M 277.74M 285.02M -0.01M 12.74M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash -48.64M 16.02M 31.16M -153.60M -21.48M
Operating Cash 681.87M 1089.60M 609.65M 91.30M 114.54M
Free Cash Flow 159.93M 712.76M -99.25M -56.74M 56.07M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
WINDLAS
Windlas Biotech 		-3.15 -0.41% 764.50 16029.28 23.94
SUNPHARMA
Sun Pharmaceutical Industries Limited 		-34.90 -2.02% 1693.60 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-50.00 -0.85% 5856.50 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		-124.10 -3.02% 3987.20 1362716.66 63.48
CIPLA
Cipla Limited 		-3.50 -0.29% 1192.40 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.